Priority of Treatment Outcomes for Caregivers and Patients with Mild Cognitive Impairment: Preliminary Analyses

被引:30
|
作者
Gonzalez Barrios, Polaris [1 ]
Pabon Gonzalez, Ricardo [1 ]
Hanna, Sherrie M. [2 ]
Lunde, Angela M. [2 ]
Fields, Julie A. [2 ]
Locke, Dona E. C. [3 ]
Smith, Glenn E. [4 ]
机构
[1] Ponce Sch Med & Hlth Sci, Ponce, PR USA
[2] Mayo Clin, Dept Psychiat & Psychol, Div Neurocognit Disorders, Rochester, MN USA
[3] Mayo Clin, Dept Psychiat & Psychol, Scottsdale, AZ USA
[4] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA
关键词
Alzheimer's disease; Caregivers; Mild cognitive impairment; Patient preference; Quality of life;
D O I
10.1007/s40120-016-0049-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The patient-centered movement advocates for greater attention to the outcomes that mattermost to patients and their families. In neurodegenerative disease, determination of patient and caregiver priorities has received scant attention in part because dementia patients are deemed unreliable reporters. However, people with mild cognitive impairment (MCI) likely retain capacity to report their preferences. Methods: In two separate MCI cohorts, we conducted preliminary analyses of patient and caregiver priorities among seven patient and five caregiver outcomes of the HABIT (R) Healthy Action to Benefit Independence & Thinking program (Mayo Clinic, Rochester, MN, USA). Results: Via interview and paper-and-pencil reporting both patient and caregiver respondents' ranked patient and caregiver quality of life and patient self-efficacy as highest priorities, ranking them ahead of patient and caregiver mood, patient functional status, patient distressing behaviors and caregiver burden. Patients and caregivers tended to value the outcomes for their loved ones higher than their own outcomes. Conclusion: Caregivers appeared to be reasonable, but not perfect, proxies for patient reports. Additional research with larger cohorts and a more comprehensive range of outcomes is needed.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 50 条
  • [31] Cognitive rehabilitation in patients with mild cognitive impairment
    Kurz, Alexander
    Pohl, Corina
    Ramsenthaler, Michaela
    Sorg, Christian
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 24 (02) : 163 - 168
  • [32] Treatment of the mild cognitive impairment (MCI)
    Allain, Herve
    Bentue-Ferrer, Daniele
    Akwa, Yvette
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (04) : 189 - 197
  • [33] Antioxidants for the treatment of mild cognitive impairment
    Mecocci, P
    Mariani, E
    Cornacchiola, V
    Polidori, AC
    NEUROLOGICAL RESEARCH, 2004, 26 (05) : 598 - 602
  • [34] Treatment of Mild Cognitive Impairment (MCI)
    Farlow, M. R.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (04) : 362 - 367
  • [35] Mild cognitive impairment:: a treatment at last?
    Allain, H
    Bentué-Ferrer, D
    Akwa, Y
    LANCET NEUROLOGY, 2004, 3 (11): : 643 - 643
  • [36] DRUG TREATMENT OF MILD COGNITIVE IMPAIRMENT
    de Velasco Soriano, R. Martinez
    Benitez Cerezo, E.
    Erausquin Sierra, C.
    Gobernado Ferrando, I.
    De la Serna De Pedro, I.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [37] Treatment of mild vascular cognitive impairment
    Kopchak, O.
    JOURNAL OF NEUROLOGY, 2013, 260 : S167 - S167
  • [38] Effects of leukoaraiosis on outcomes of mild cognitive impairment
    Zheng, L.
    Xu, G.
    Lu, G.
    Liu, X.
    CEREBROVASCULAR DISEASES, 2007, 24 (06) : 491 - 491
  • [39] Alpha-synuclein in CSF of mild cognitive impairment patients: a preliminary study
    Monge-Argiles, J-A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 241 - 241
  • [40] DREAMS OF INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT: A PRELIMINARY STUDY
    Kamal, F.
    Murkar, A.
    Morrison, C.
    Banks, M.
    Taler, V.
    De Koninck, J.
    SLEEP MEDICINE, 2019, 64 : S88 - S88